EMA Proposes New COVID-19 Treatment for Approval

Summary

The European Medicines Agency (EMA) has issued a new proposal for the approval of a potential COVID-19 treatment, following a recent review of clinical trial data. The proposal is currently under review by the EMA's Committee for Medicinal Products for Human Use (CHMP).